Used as an anticoagulant to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. It is also indicated for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), particularly following hip or knee replacement surgery. As a factor Xa inhibitor, it works by blocking a key component in the blood clotting process, offering effective clot prevention with a lower risk of bleeding compared to older anticoagulants. Its predictable pharmacokinetics allows for fixed dosing without routine coagulation monitoring, making it convenient for long-term use.